What's the difference between the annual review invite folders "All" and "QOF and Opts In Only"?

When sending annual review invites, there are two folders to chose from:

2c Invites I AR I All

2d Invites I AR I QOF and Opt Ins Only

But what's the difference?!

• QOF and Opt Ins Only

It's easiest to start by explaining what we include in QOF and Opt Ins Only. By QOF, we mean Annual Reviews needed to achieve QOF targets. We also include Learning Disability health checks in this list.  Although they're not part of QOF, they're a significant practice target that all practices prioritise.

This is the current list of Annual Reviews we include in QOF:

• Asthma
• COPD
• Dementia*
• Diabetes
• Heart Failure (Physical and Medication Review)
• Hypertension
• Learning Disability Health Check*
• Mental Health (Physical Checks and Care Plan)*
• Non-diabetic Hyperglycaemia / Pre-Diabetes
• Secondary Prevention of Coronary Heart Disease
• Stroke And Transient Ischaemic Attacks (TIA)

*can be removed from practice invites if you prefer to invite these separately

Opt Ins include three elements:

1) Any additional reviews your practice has opted into:

• Epilepsy
• High Risk CVD (QRISK>10%)
• Proactive Care - Care plan Admissions Avoidance Register
• Women's health: CHC, POP
• Women's health: Depo Provera (inc Sayana Press)
• Women's health: HRT
• Women's health: Vaginal Oestrogen HRT

2) Patients who've had annual monitoring configured using our Select Tests for Monitoring template

3) Reviews your practice has opted to always include in this invite section. For example, CKD, or patients who need annual medication monitoring.

• All

"All", as the name suggests(!), includes everything in QOF and Opts in Only...

AND other conditions that should have annual monitoring:

• Atrial Fibrillation**
• Bariatric Surgery
• Chronic Kidney Disease
• Coeliac**
• Familial Hypercholesterolaemia
• Haemochromatosis**
• MGUS (Monoclonal Gammopathy of Unknown Significance)**
• Fatty Liver Disease / MASLD / NAFLD
• PCOS**
• Peripheral Arterial Disease
• Primary biliary cirrhosis
• Prostate Cancer
• Rheumatoid Arthritis**
• Thyroid Conditions
• Thyroid Peroxidase (Raised)**

AND any medications that need annual monitoring:

• ACE/ARB
• Acetazolamide
• Agomelatine
• Aliskiren
• Antipsychotics
• B12 (Oral only)
• Calcium Supplements (with CKD diagnosis)
• Carbamazepine
• Combined Hormonal Contraception
• Corticosteroids (Oral) (unless monitored more frequently) 
• Digoxin 
• DOAC (unless monitored more frequently)
• Gout and Uric acid metabolism drugs
• HRT
• Iron
• Ivabradine
• Lipid Regulating Agent (e.g. Statin / Ezetimibe) on repeat (if already having annual bloods)
• Magnesium
• Mesalazine / Olsalazine / Balsalazide
• Metformin
• NSAIDS (on repeat or issued >9 times in last 12m)**
• Paracetamol (on repeat or issued >9 times in last 12m)
• Phenytoin
• Prostate Meds (e.g. Finasteride)
• Riluzole
• Sulfasalazine
• Testosterone Replacement
• Theophylline
• Thiazides and related diuretics
• Thyroid Hormones
• Valproate (e.g. Epilim) / Valproic Acid

**can be opted out of as a practice

This is obviously a much longer list but there will be a lot of overlap and so the numbers of patients may not be that much higher.

Many practices aim to send All invites, but find at times of high demand or low capacity, they prefer to revert to the QOF and Opts In Only invites if needed.